Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting120%
withdrawn120%
completed240%
active_not_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_4

The Effect of Dapagliflozin on Patients With Cardiomyopathy

NCT07076615
completednot_applicable

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

NCT05174312
active_not_recruiting

Long-term Use of CCB and Breast Cancer Risk

NCT05972785
completed

Acute Renal Injury After Major Elective Non-Cardiac Surgery

NCT04600271
withdrawnnot_applicable

Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops

NCT01661777

Clinical Trials (5)

Showing 5 of 5 trials
NCT07076615Phase 4

The Effect of Dapagliflozin on Patients With Cardiomyopathy

Recruiting
NCT05174312Not Applicable

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

Completed
NCT05972785

Long-term Use of CCB and Breast Cancer Risk

Active Not Recruiting
NCT04600271

Acute Renal Injury After Major Elective Non-Cardiac Surgery

Completed
NCT01661777Not Applicable

Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5